Hahaha hahahaha hahahaha hahaha haha ok 🤦‍♀️
Ik lach er maar om.

Het is zóveel zeggend.

#journalistiek #nivo

PomeGran Celebrates Top Ranking and New Rural ISP Launch, NIVO PomeGran Inc. proudly celebrates its recognition as Canada's fastest-growing telecom provider with the launch of NIVO, enhancing rural internet access.

PomeGran Celebrates Top Ranking and New Rural ISP Launch, NIVO #Canada #Toronto #PomeGran #NIVO #Rural_ISP

This @oncoalert.bsky.social Round up is chock full of #GIonc goodness.

⭐️FDA approval of #IPI + #NIVO for dMMR #crcsm

⭐️ 5 year update on #DYNAMIC 💥 trial use of #ctDNA 🧬🩸 in stage II #crcsm

Never miss an update by signing up today:
🔗 oncoalert.m-pages.com/nhMpwe/oncoale…

Meaning of #nivo NIVO: In Chile, scrape or bark of medicinal plants... nivo

Significado de #nivo ÑIVO: En Chile, raspadura o corteza de plantas medicinales... nivo

Significado de #nivo NIVO: Em Chile, arranhão ou casca de plantas medicinais... nivo

Prof Hussein Tawbi #melanoma #Immunotherapy guru @mdanderson.bsky.social talks evolution of first line therapy. Highlights #LAG3 & lays out summary of what may be optimal for first line therapy & what looks promising/ #PD1 #CTLA4 #nivo #Ipi @bmsnews.bsky.social
#BRIDGE2024 @sitcancer.bsky.social

4) Prof Michael Postow #melanoma #immunotherapy Expert @mskcancercenter.bsky.social How many doses of #neoadjuvant #IPI #Nivo checkpoint blockade? WE DON’T KNOW!! Radiomics - adds to RECIST SD & PD ? @sitcancer.bsky.social #Bridge2024 @impactmelanoma.bsky.social @melanomaresearch.bsky.social

Pt had a Path CR & had CD8 going into tumor. However, same true for nonresponder. NEED TO ID FUNCTIONAL PROPERTIES

3) Prof Michael Postow #melanoma #immunotherapy Expert @mskcancercenter.bsky.social How many doses of #neoadjuvant #IPI #Nivo checkpoint blockade? Can we reduce toxicity & maintain efficacy? @sitcancer.bsky.social #Bridge2024 @impactmelanoma.bsky.social @melanomaresearch.bsky.social #FinishCancer

2) Prof Michael Postow #melanoma #immunotherapy Expert @mskcancercenter.bsky.social How many doses of #neoadjuvant #IPI #Nivo checkpoint blockade? Can we reduce toxicity & maintain efficacy? @sitcancer.bsky.social #Bridge2024 @impactmelanoma.bsky.social @melanomaresearch.bsky.social #MRA

4) Prof Leisha Emens #breast #cancer #immunotherapy expert @ #KaiserPermanente & President @sitcancer.bsky.social discusses success of 💥NO CHEMO😀#neoadjuvant immunotherapy for #TNBC / #ipi + #nivo best/CD8 distance to tu cell correlated with response/non resp had >Treg/ #Bridge2024 #FinishCancer

3) Prof Leisha Emens #breast #cancer #immunotherapy expert @ #KaiserPermanente & President @sitcancer.bsky.social discusses success of 💥NO CHEMO😀#neoadjuvant immunotherapy for #TNBC / #ipi + #nivo best/CD8 distance to tu cell correlated with response/non resp had >Treg/ #Bridge2024 #FinishCancer

2) Prof Leisha Emens #breast #cancer #immunotherapy expert @ #KaiserPermanente & President @sitcancer.bsky.social discusses success of 💥NO CHEMO😀#neoadjuvant immunotherapy for #TNBC / #ipi + #nivo best/CD8 distance to tu cell correlated with response/non resp had >Treg/ #Bridge2024 #FinishCancer

1) Prof Leisha Emens #breast #cancer #immunotherapy expert @ #KaiserPermanente & President @sitcancer.bsky.social discusses success of 💥NO CHEMO😀#neoadjuvant immunotherapy for #TNBC / #ipi + #nivo best/CD8 distance to tu cell correlated with response/non resp had >Treg/ #Bridge2024 #FinishCancer

5) 💥Dr Taube WINS DEBATE! argues that multiple different mIF assays show improved outcome. Can triage patients who won’t do well with #Ipi + #Nivo & needs something else - argues it beats IFNg signature/ #Hopkins #pathology @jhmedarchives.bsky.social #JEDIcouncil #Bridge2024 @sitcancer.bsky.social

2) Drs Robert Ferris & Tony Choueiri debate #chemo + #IO at #Immunotherapy #Bridge2024 / Bob argues chemo gives early benefit but negative impact on long-term. Argues doublet IO (combo #IPI + #nivo) eliminates negative upfront benefit & maintain long-term benefit #FinishCancer @sitcancer.bsky.social

Drs Robert Ferris & Tony Choueiri debate #chemo + #IO at #Immunotherapy #Bridge2024 / Bob argues chemo gives early benefit but negative impact on long-term. Argues doublet IO (combo #IPI + #nivo) eliminates negative upfront benefit & maintain long-term benefit #FinishCancer @sitcancer.bsky.social

Prof. Robert Ferris #headandneckcancer #surgical #oncologist Guru @ UNC talks about #neoadjuvant #immunotherapy/ exciting data/do not post/interesting #LAG3 biomarker data/ #nivo + #Rela / #BRIDGE2024 @sitcancer.bsky.social / great discussion/Cites Drs Bell, Leidner & Crittenden #FinishCancer